Point72 Hong Kong LTD Aclaris Therapeutics, Inc. Transaction History

Point72 Hong Kong LTD

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	SELL	$9.74 - $17.92 $17,376 - $31,969	-1,784 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$12.27 - $18.49 $21,889 - $32,986	1,784 New	1,784 $26,000
Q3 2021 Nov 15, 2021	SELL	$13.38 - $18.8 $31,817 - $44,706	-2,378 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$17.08 - $29.6 $40,616 - $70,388	2,378 New	2,378 $42,000
Q4 2019 Feb 14, 2020	SELL	$1.02 - $1.97 $6,280 - $12,129	-6,157 Closed	0 $0
Q3 2019 Nov 14, 2019	BUY	$0.79 - $2.47 $322 - $1,007	408 Added 7.1%	6,157 $7,000
Q2 2019 Aug 14, 2019	BUY	$2.13 - $7.06 $12,245 - $40,587	5,749 New	5,749 $13,000
Q2 2018 Aug 14, 2018	SELL	$16.46 - $20.33 $6,979 - $8,619	-424 Closed	0 $0
Q1 2018 May 15, 2018	BUY	$17.08 - $25.64 $6,866 - $10,307	402 Added 1827.27%	424 $7,000
Q4 2017 Feb 14, 2018	SELL	$21.47 - $27.8 $558 - $722	-26 Reduced 54.17%	22 $1,000
Q3 2017 Nov 14, 2017	BUY	$23.02 - $28.8 $1,104 - $1,382	48	48 $1,000

50.7M

30.6K

Ticker ACRS
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 66,671,800
Market Cap $255M
Description
Aclaris Therapeutics, Inc. operates a clinical-stage biopharmaceutical company, develops novel drug candidates for immune-inflammatory diseases in the United States. It operates through two segments: Therapeutics and Contract Research. The Therapeutics segment is involved in identifying and developing innovative therapies to address significant ...

Get notified when there are updates to the investment portfolio of Point72 Hong Kong LTD, based on Form 13F filings with the SEC.

Stay updated on Point72 Hong Kong LTD with notifications on news.